FINTLEPLA®▼ (fenfluramine) oral solution gains approval in Japan as adjunctive therapy for seizures linked with Lennox-Gastaut syndrome (LGS)
UCB’s FINTEPLA®▼ (fenfluramine) oral solution has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating seizures linked with Lennox-Gastaut syndrome (LGS) as an additional therapy alongside other anti-epileptic medications for patients aged two and above.…